Healthcare Triangle (HCTI) Gains from Sales and Divestitures (2023 - 2025)

Healthcare Triangle has disclosed Gains from Sales and Divestitures across 3 years of filings, most recently posting $583000.0 for Q3 2025.

• Gains from Sales and Divestitures for Q3 2025 came in at $583000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $583000.0 (changed 0.0% YoY), and the FY2024 annual result was $193451.0, up 58.63% from the prior year.
• Gains from Sales and Divestitures came in at $583000.0 for Q3 2025 at Healthcare Triangle, down from $1.5 million in the prior quarter.
• In the past five years, Gains from Sales and Divestitures ranged from a high of $1.5 million in Q2 2025 to a low of $48363.0 in Q1 2024.
• The 3-year median for Gains from Sales and Divestitures is $157701.5 (2023), against an average of $391084.5.
• Peak annual rise in Gains from Sales and Divestitures reached 1403.03% in 2025, while the deepest fall reached 0.0% in 2025.
• Healthcare Triangle's Gains from Sales and Divestitures stood at $121952.0 in 2023, then surged by 58.63% to $193451.0 in 2024, then jumped by 201.37% to $583000.0 in 2025.
• The last three Gains from Sales and Divestitures figures came in at $583000.0 (Q3 2025), $1.5 million (Q2 2025), and $48363.0 (Q1 2025), per Business Quant data.